Susquehanna International Group, LLP Aveo Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$8.48 - $14.97 $1.12 Million - $1.97 Million	-131,900 Reduced 58.13%	95,000 $1.42 Million
Q3 2022 Nov 14, 2022	BUY	$6.61 - $8.72 $142,115 - $187,480	21,500 Added 10.47%	226,900 $1.87 Million
Q2 2022 Aug 15, 2022	BUY	$3.51 - $6.67 $25,623 - $48,691	7,300 Added 3.69%	205,400 $1.35 Million
Q1 2022 May 16, 2022	BUY	$3.15 - $6.01 $68,040 - $129,816	21,600 Added 12.24%	198,100 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$4.69 - $7.4 $132,727 - $209,420	28,300 Added 19.1%	176,500 $828,000
Q3 2021 Nov 15, 2021	SELL	$5.12 - $6.89 $96,256 - $129,532	-18,800 Reduced 11.26%	148,200 $916,000
Q2 2021 Aug 11, 2021	SELL	$6.21 - $7.45 $943,299 - $1.13 Million	-151,900 Reduced 47.63%	167,000 $1.1 Million
Q1 2021 May 17, 2021	BUY	$5.97 - $15.28 $669,237 - $1.71 Million	112,100 Added 54.21%	318,900 $2.33 Million
Q4 2020 Feb 16, 2021	SELL	$5.08 - $6.68 $185,420 - $243,820	-36,500 Reduced 15.0%	206,800 $1.19 Million
Q3 2020 Nov 16, 2020	SELL	$4.16 - $6.26 $279,968 - $421,298	-67,300 Reduced 21.67%	243,300 $1.45 Million
Q2 2020 Aug 14, 2020	BUY	$3.47 - $9.99 $574,632 - $1.65 Million	165,600 Added 114.21%	310,600 $1.6 Million
Q1 2020 May 15, 2020	BUY	$2.6 - $6.9 $377,000 - $1 Million	145,000 New	145,000 $525,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.